Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research underway to give sleep apnea sufferers relief and rest

30.09.2008
For some, a full night’s rest can be anything but restful. That’s because they have sleep apnea, which causes them to struggle for breath in bouts throughout the night. Six percent of the population is affected by the condition—but many don’t even know they have it.

“They don’t make the connection between the fact that they snore loudly at night and they complain about being tired during the day,” says Samuel Krachman, D.O. , professor of medicine and director of the Sleep Disorders Center at Temple University School of Medicine and Hospital. “They think that they’re just tired, not getting enough sleep or just working too hard. But in reality, it’s related to the sleep apnea.”

Krachman is leading research on an experimental device to help patients who suffer from positional sleep apnea. Positional sleep apnea refers to patients who have episodes where they stop breathing when they’re on their back, but when they are on their side, the abnormal breathing resolves. Fifty percent of patients with mild sleep apnea (those who experience anywhere from five to 15 events an hour) and 20 percent of people with moderate sleep apnea (15 to 30 events an hour) have positional sleep apnea. Krachman explains how wearing the device, called Zzoma, works to reduce those episodes.

“Zzoma is a device which is worn around the chest area like a belt, with a device on the back, which is a firm, foam material wrapped in canvas to keep them from moving on their backs. Over the last year, we’ve been studying its use in treating patients with mild to moderate positional sleep apnea.”

The device was created by former Temple Fellow Joseph G. Crocetti. He and Krachman have worked together to treat positional sleep apnea. Their research has shown that the Zzoma device is less obtrusive and easier to use than the leading alternative, a continuous positive airway pressure machine or CPAP, a mask that blows air on a person’s face to keep the airway open.

“Although CPAP is very effective, the best studies have shown it’s only used correctly 50 percent of the time,” says Krachman. “That leaves many diagnosed with sleep apnea but not treated.”

Untreated sleep apnea can lead to a host of other medical problems. Just having sleep apnea is an independent risk factor for developing high blood pressure, coronary disease and heart failure. That’s why Krachman hopes the FDA approves Zzoma to treat positional sleep apnea, to give sufferers an effective alternative to the burden of CPAP.

For more information on the Temple Sleep Disorders Center, call 215-707-8163.

Megan Chiplock | EurekAlert!
Further information:
http://www.temple.edu
http://www.temple.edu/newsroom/2008_2009/09/stories/sleepapnea.htm

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

Quantum optical sensor for the first time tested in space – with a laser system from Berlin

23.01.2017 | Physics and Astronomy

The interactome of infected neural cells reveals new therapeutic targets for Zika

23.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>